Cowen Prime Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $115K | Sell |
1,800
-300
| -14% | -$20.1K | 0.04% | 103 |
|
|
2023
Q1 | $140K | Hold |
2,100
| – | – | 0.06% | 95 |
|
|
2022
Q4 | $151K | Hold |
2,100
| – | – | 0.06% | 95 |
|
|
2022
Q3 | $149K | Hold |
2,100
| – | – | 0.09% | 80 |
|
|
2022
Q2 | $162K | Hold |
2,100
| – | – | 0.09% | 81 |
|
|
2022
Q1 | $153K | Hold |
2,100
| – | – | 0.06% | 89 |
|
|
2021
Q4 | $131K | Hold |
2,100
| – | – | 0.04% | 91 |
|
|
2021
Q3 | $124K | Hold |
2,100
| – | – | 0.05% | 91 |
|
|
2021
Q2 | $140K | Hold |
2,100
| – | – | 0.05% | 89 |
|
|
2021
Q1 | $133K | Hold |
2,100
| – | – | 0.05% | 93 |
|
|
2020
Q4 | $130K | Hold |
2,100
| – | – | 0.06% | 86 |
|
|
2020
Q3 | $127K | Hold |
2,100
| – | – | 0.06% | 86 |
|
|
2020
Q2 | $162K | Hold |
2,100
| – | – | 0.09% | 81 |
|
|
2020
Q1 | $117K | Hold |
2,100
| – | – | 0.07% | 83 |
|
|
2019
Q4 | $135K | Hold |
2,100
| – | – | 0.06% | 83 |
|
|
2019
Q3 | $106K | Hold |
2,100
| – | – | 0.05% | 89 |
|
|
2019
Q2 | $95K | Hold |
2,100
| – | – | 0.05% | 96 |
|
|
2019
Q1 | $100K | Hold |
2,100
| – | – | 0.05% | 93 |
|
|
2018
Q4 | $109K | Hold |
2,100
| – | – | 0.07% | 88 |
|
|
2018
Q3 | $130K | Hold |
2,100
| – | – | 0.06% | 99 |
|
|
2018
Q2 | $116K | Sell |
2,100
-6,000
| -74% | -$324K | 0.06% | 101 |
|
|
2018
Q1 | $512K | Hold |
8,100
| – | – | 0.28% | 57 |
|
|
2017
Q4 | $496K | Sell |
8,100
-1,000
| -11% | -$62.5K | 0.24% | 61 |
|
|
2017
Q3 | $580K | Hold |
9,100
| – | – | 0.28% | 56 |
|
|
2017
Q2 | $507K | Hold |
9,100
| – | – | 0.23% | 58 |
|
|
2017
Q1 | $495K | Buy |
9,100
+700
| +8% | +$38.4K | 0.25% | 57 |
|
|
2016
Q4 | $491K | Hold |
8,400
| – | – | 0.26% | 55 |
|
|
2016
Q3 | $453K | Sell |
8,400
-1,500
| -15% | -$96.4K | 0.21% | 82 |
|
|
2016
Q2 | $728K | Buy |
9,900
+1,100
| +13% | +$77.7K | 0.35% | 55 |
|
|
2016
Q1 | $562K | Sell |
8,800
-200
| -2% | -$12.6K | 0.26% | 62 |
|
|
2015
Q4 | $619K | Hold |
9,000
| – | – | 0.27% | 62 |
|
|
2015
Q3 | $533K | Sell |
9,000
-1,500
| -14% | -$95.2K | 0.25% | 62 |
|
|
2015
Q2 | $699K | Sell |
10,500
-176
| -2% | -$11.6K | 0.27% | 55 |
|
|
2015
Q1 | $689K | Buy |
10,676
+1,500
| +16% | +$93.9K | 0.28% | 54 |
|
|
2014
Q4 | $542K | Hold |
9,176
| – | – | 0.21% | 61 |
|
|
2014
Q3 | $470K | Buy |
9,176
+1
| +0% | +$50 | 0.21% | 61 |
|
|
2014
Q2 | $445K | Sell |
9,175
-1,000
| -10% | -$49.3K | 0.17% | 57 |
|
|
2014
Q1 | $529K | Buy |
10,175
+675
| +7% | +$35.9K | 0.2% | 55 |
|
|
2013
Q4 | $505K | Hold |
9,500
| – | – | 0.19% | 57 |
|
|
2013
Q3 | $440K | Buy |
9,500
+1,000
| +12% | +$43.9K | 0.17% | 70 |
|
|
2013
Q2 | $381K | Buy |
+8,500
| New | +$369K | 0.16% | 72 |
|
Other funds holding BMY
Cowen Prime Advisors's BMY Position: Q2 2023 in Review
Cowen Prime Advisors reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2023, selling an estimated $20.1K and leaving 1,800 shares worth $115K. The position accounts for 0.04% of the portfolio, ranked #103.
Cowen Prime Advisors first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $728K in Q2 2016. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Cowen Prime Advisors held 1,800 shares of Bristol-Myers Squibb worth $115K as of Q2 2023.
- Cowen Prime Advisors sold 300 Bristol-Myers Squibb shares in Q2 2023, an estimated $20.1K.
- Bristol-Myers Squibb made up 0.04% of Cowen Prime Advisors's portfolio in Q2 2023, its #103 holding.
- Cowen Prime Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
- Cowen Prime Advisors's Bristol-Myers Squibb position peaked at $728K in Q2 2016.
- 2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.